Seasoned investor and operator focused on technology and consumer growth equity, bringing hands-on scaling experience and deal execution across venture and private markets. Adam Weisner is a former founder and investment professional who combines financial analysis, capital-raising and board-level governance to drive revenue expansion and operational improvements. He specializes in growth-stage value creation, strategic M&A and structuring follow-on financings for founder-led businesses.
Seasoned investor and operator focused on technology and consumer growth equity, bringing hands-on scaling experience and deal execution across venture and private markets. Adam Weisner is a former founder and investment professional who combines financial analysis, capital-raising and board-level governance to drive revenue expansion and operational improvements. He specializes in growth-stage value creation, strategic M&A and structuring follow-on financings for founder-led businesses.
Focuses on growth equity in technology and consumer businesses, prioritizing founder-led companies with clear unit economics and scalable go-to-market models. Emphasizes active board-level partnership, operational roadmaps and follow-on financing cadence to accelerate revenue expansion and margin improvement. Employs rigorous financial underwriting, milestone-based capital deployment and a multi-stage exit time horizon of three to seven years. Risk is managed via stage-appropriate covenants, concentrated but diversified sector exposure, and a bias toward companies where hands-on operating experience drives measurable value creation.
Focuses on growth equity in technology and consumer businesses, prioritizing founder-led companies with clear unit economics and scalable go-to-market models. Emphasizes active board-level partnership, operational roadmaps and follow-on financing cadence to accelerate revenue expansion and margin improvement. Employs rigorous financial underwriting, milestone-based capital deployment and a multi-stage exit time horizon of three to seven years. Risk is managed via stage-appropriate covenants, concentrated but diversified sector exposure, and a bias toward companies where hands-on operating experience drives measurable value creation.
| Trades 506 | Longs Won 326/506 64% | Profit Factor 2.27 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.81M |
| Average Win $792,186.55 | Best Trade (Aug 17) $51.63M | Sharpe Ratio -1.14 |
| Average Loss -$632,822.52 | Worst Trade (Mar 31) -$45.23M | Z-Score 2.39 (98.29%) |
| Commissions $0 | Avg. Trade Length 6m 1w 1d | Expectancy $284,566.7 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.27% |
| Consecutive Losing Trades | 2,268 | 2,041 | 1,814 | 1,587 | 1,361 | 1,134 | 907 | 680 | 454 | 227 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 24,299 | $6.27M | $7.95M | - | $1.68M | 26.88% | +0.677% |
ABBV AbbVie Inc. | 27,808 | $6.34M | $7.26M | - | $928,426.28 | 14.66% | -0.199% |
ABT Abbott Laboratories | 43,409 | $5.3M | $4.71M | - | -$581,948.25 | -10.99% | -1.684% |
ADP Automatic Data Processing Inc. | 21,073 | $5.19M | $5.96M | - | $775,049.44 | 14.93% | +0.676% |
AMGN Amgen Inc. | 17,242 | $5.67M | $7.65M | - | $1.97M | 34.77% | +0.16% |
AMT American Tower Corporation | 28,891 | $4.99M | $5.15M | - | $168,579.46 | 3.38% | +3.178% |
AMZN Amazon.com Inc | 15,092 | $3.44M | $3.91M | - | $472,612.09 | 13.75% | +1.602% |
AVGO Broadcom Inc. | 17,865 | $6.18M | $6.38M | - | $199,467.68 | 3.23% | -2.718% |
AZN AstraZeneca PLC American Depositary Shares | 33,173 | $6.54M | $5.46M | - | -$1.08M | -16.56% | +1.813% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 2,541 | $232,196.65 | $232,285.51 | - | $88.86 | 0.04% | +0.016% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 496,303 | $38.61M | $37.22M | - | -$1.38M | -3.58% | +0.16% |
BND Vanguard Total Bond Market Index Fund | 422,886 | $31.07M | $30.43M | - | -$636,065.81 | -2.05% | +0.188% |
| BPRE BPRE | 219,883 | $3.3M | $3.65M | - | $354,012 | 10.73% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 10,458 | $5.25M | $5.3M | - | $59,142.94 | 1.13% | +0.392% |
C Citigroup Inc. | 54,166 | $6.31M | $7.48M | - | $1.17M | 18.48% | +2.799% |
CION Cion Investment Corporation | 143,122 | $1.38M | $1.06M | - | -$323,601.16 | -23.38% | -0.55% |
COP ConocoPhillips | 79,821 | $8.7M | $10.85M | - | $2.16M | 24.78% | -0.878% |
CRM Salesforce Inc | 17,292 | $3.23M | $4.6M | - | $1.37M | 42.57% | +3.581% |
CVX Chevron Corporation | 33,020 | $5.09M | $6.99M | - | $1.9M | 37.36% | -0.113% |
CW Curtiss-Wright Corporation | 400 | $220,508 | $227,186 | - | $6,678 | 3.03% | +1.146% |